Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder

Neuropsychopharmacology

Volumn 33, Issue 6, 2008, Pages 1229-1238

  Bearden, Carrie E ^a,k   Thompson, Paul M ^b   Dutton, Rebecca A ^b   Frey, Benício N ^c,d   Peluso, Marco A M ^c,e   Nicoletti, Mark ^f   Dierschke, Nicole ^c   Hayashi, Kiralee M ^b   Klunder, Andrea D ^b   Glahn, David C ^c   Brambilla, Paolo ^g,h   Sassi, Roberto B ^e,i   Mallinger, Alan G ^j   Soares, Jair C ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g E Medea   (Italy)

^h UNIVERSITY OF UDINE   (Italy)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Brain mapping; Hippocampus; Magnetic resonance imaging; Medication effects; Mood disorder; Neurotrophins

Indexed keywords

LITHIUM;

ADULT; AGED; AMNESIA; ARTICLE; BIPOLAR DISORDER; BRAIN MAPPING; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; DRUG HALF LIFE; FEMALE; HIPPOCAMPUS; HUMAN; MALE; NERVE CELL NETWORK; NEUROANATOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAMETRIC TEST; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; BRAIN MAPPING; FEMALE; HIPPOCAMPUS; HUMANS; IMAGING, THREE-DIMENSIONAL; LITHIUM COMPOUNDS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 42049099907     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301507     Document Type: Article

References (54)

1. Altshuler LL, Ventura J, van Gorp WG, Green MF, Theberge DC, Mintz J (2004). Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects. Biol Psychiatry 56: 560-569.
2. Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL et al (2006). Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol 63: 693-699.
3. Bearden CE, Glahn DC, Monkul ES, Barrett J, Najt P, Kaur S et al (2006). Sources of declarative memory impairment in bipolar disorder: mnemonic processes and clinical features. J Psychiatr Res 40: 47-58.
4. Bearden CE, Thompson PM, Dalwani M, Hayashi KM, Lee AD, Nicoletti M et al (2007). Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry 62: 7-16.
5. Bech P, Bolwig TG, Kramp P, Rafaelsen OJ (1979). The Bech-Rafaelsen mania scale and the hamilton depression scale. Acta Psychiatr Scand 59: 420-430.
6. Becker JT, Davis SW, Hayashi KM, Meltzer CC, Toga AW, Lopez OL et al (2006). Three-dimensional patterns of hippocampal atrophy in mild cognitive impairment. Arch Neurol 63: 97-101.
7. Benes FM, Kwok EW, Vincent SL, Todtenkopf MS (1998). A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry 44: 88-97.
8. Brambilla P, Glahn DC, Balestrieri M, Soares JC (2005). Magnetic resonance findings in bipolar disorder. Psychiatr Clin North Am 28: 443-467.
9. Braus DF, Ende G, Weber-Fahr W, Demirakca T, Henn FA (2001). Favorable effect on neuronal viability in the anterior cingulate gyrus due to long-term treatment with atypical antipsychotics: an MRSI study. Pharmacopsychiatry 34: 251-253.
10. Chen G, Rajkowska G, Du F, Seraji-Bozorgzad N, Manji HK (2000). Enhancement of hippocampal neurogenesis by lithium. J Neurochem 75: 1729-1734.
11. Chen G, Zeng WZ, Yuan PX, Huang LD, Jiang YM, Zhao ZH et al (1999). The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 72: 879-882.
12. Csernansky JG, Wang L, Jones D, Rastogi-Cruz D, Posener JA, Heydebrand G et al (2002). Hippocampal deformities in schizophrenia characterized by high dimensional brain mapping. Am J Psychiatry 159: 2000-2006.
13. Csernansky JG, Wang L, Swank J, Miller JP, Gado M, McKeel D et al (2005). Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly. Neuroimage 25: 783-792.
14. Duman RS, Monteggia LM (2006). A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59: 1116-1127.
15. Duning T, Kloska S, Steinstrater O, Kugel H, Heindel W, Knecht S (2005). Dehydration confounds the assessment of brain atrophy. Neurology 64: 548-550.
16. Duvernoy H (1988). The Human Hippocampus: An Atlas of Applied Anatomy. JF Bergman Verlag: Munich, Germany.
17. Eichenbaum H, Fortin NJ (2005). Bridging the gap between brain and behavior: cognitive and neural mechanisms of episodic memory. J Exp Anal Behav 84: 619-629.
18. First MB, Spitzer RL, Gibbon M, Williams JBW (1996). Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Patient Edition. Biometrics Research Department, New York State Psychiatric Institute: New York.
19. Frisoni GB, Sabattoli F, Lee AD, Dutton RA, Toga AW, Thompson PM (2006). In vivo neuropathology of the hippocampal formation in AD: A radial mapping MR-based study. Neuroimage 32: 104-110.
20. Gogtay N, Nugent III TF, Herman DH, Ordonez A, Greenstein D, Hayashi KM et al (2006). Dynamic mapping of normal human hippocampal development. Hippocampus 16: 664-672.
21. Gourovitch ML, Torrey EF, Gold JM, Randolph C, Weinberger DR, Goldberg TE (1999). Neuropsychological performance of monozygotic twins discordant for bipolar disorder. Biol Psychiatry 45: 639-646.
22. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
23. Hwang J, Lyoo IK, Dager SR, Friedman SD, Oh JS, Lee JY et al (2006). Basal ganglia shape alterations in bipolar disorder. Am J Psychiatry 163: 276-285.
24. Kempermann G (2002). Regulation of adult hippocampal neurogenesis - implications for novel theories of major depression. Bipolar Disord 4: 17-33.
25. Kieseppa T, Tuulio-Henriksson A, Haukka J, Van Erp T, Glahn D, Cannon TD et al (2005). Memory and verbal learning functions in twins with bipolar-I disorder, and the role of information-processing speed. Psychol Med 35: 205-215.
26. Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS et al (2005). Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 62: 361-370.
27. Linden DE (2006). How psychotherapy changes the brain - the contribution of functional neuroimaging. Mol Psychiatry 11: 528-538.
28. Manji HK, Moore GJ, Chen G (2000a). Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol Psychiatry 48: 740-754.
29. Manji HK, Moore GJ, Chen G (2000b). Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. J Clin Psychiatry 61(Suppl 9): 82-96.
30. Marangell LB, Ketter TA, George MS, Pazzaglia PJ, Callahan AM, Parekh P et al (1997). Inverse relationship of peripheral thyrotropin-stimulating hormone levels to brain activity in mood disorders. Am J Psychiatry 154: 224-230.
31. McDonald C, Zanelli J, Rabe-Hesketh S, Ellison-Wright I, Sham P, Kalidindi S et al (2004). Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder. Biol Psychiatry 56: 411-417.
32. Molina V, Reig S, Sanz J, Palomo T, Benito C, Sanchez J et al (2005). Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia. Schizophr Res 80: 61-71.
33. Monkul E, Dalwani M, Nicoletti M, Soares J (2004). Brain gray matter changes after lithium treatment: a voxel-based morphometry study in healthy individuals. Bio Psychiatry 55: 202S.
34. Moore GJ, Bebchuk JM, Hasanat K, Chen G, Seraji-Bozorgzad N, Wilds IB et al (2000a). Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? Biol Psychiatry 48: 1-8.
35. Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK (2000b). Lithium-induced increase in human brain grey matter. Lancet 356: 1241-1242.
36. Narr KL, Thompson PM, Szeszko P, Robinson D, Jang S, Woods RP et al (2004). Regional specificity of hippocampal volume reductions in first-episode schizophrenia. Neuroimage 21: 1563-1575.
37. Nicolson R, DeVito TJ, Vidal CN, Sui Y, Hayashi KM, Drost DJ et al (2006). Detection and mapping of hippocampal abnormalities in autism. Psychiatry Neuroimaging Res 148: 11-21.
38. Pantel J, Cretsinger K, Keefe H (2005). Hippocampus tracing guidelines. Available at http://www.psychiatry.uiowa.edu/mhcrc/pdf/papers/hippocampus.pdf. (Accessed November 1, 2005).
39. Phatak P, Shaldivin A, King LS, Shapiro P, Regenold WT (2006). Lithium and inositol: effects on brain water homeostasis in the rat. Psychopharmacology (Berlin) 186: 41-47.
40. Rajkowska G (2000). Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry 48: 766-777.
41. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S et al (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301: 805-809.
42. Sassi RB, Brambilla P, Hatch JP, Nicoletti MA, Mallinger AG, Frank E et al (2004). Reduced left anterior cingulate volumes in untreated bipolar patients. Biol Psychiatry 56: 467-475.
43. Sassi RB, Nicoletti M, Brambilla P, Mallinger AG, Frank E, Kupfer DJ et al (2002). Increased gray matter volume in lithium-treated bipolar disorder patients. Neurosci Lett 329: 243-245.
44. Silverstone PH, Wu RH, O'Donnell T, Ulrich M, Asghar SJ, Hanstock CC (2003). Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients. Int Clin Psychopharmacol 18: 73-79.
45. Starkstein SE, Fedoroff P, Berthier ML, Robinson RG (1991). Manic-depressive and pure manic states after brain lesions. Biol Psychiatry 29: 149-158.
46. Styner M, Lieberman JA, Pantazis D, Gerig G (2004). Boundary and medial shape analysis of the hippocampus in schizophrenia. Med Image Anal 8: 197-203.
47. Thompson PM, Hayashi KM, De Zubicaray GI, Janke AL, Rose SE, Semple J et al (2004a). Mapping hippocampal and ventricular change in Alzheimer disease. Neuroimage 22: 1754-1766.
48. Thompson PM, Hayashi KM, Sowell ER, Gogtay N, Giedd JN, Rapoport JL et al (2004b). Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia. Neuroimage 23(suppl 1): S2-S18.
49. Thompson PM, Schwartz C, Toga AW (1996). High-resolution random mesh algorithms for creating a probabilistic 3D surface atlas of the human brain. Neuroimage 3: 19-34.
50. van Gorp WG, Altshuler L, Theberge DC, Mintz J (1999). Declarative and procedural memory in bipolar disorder. Biol Psychiatry 46: 525-531.
51. Van Hoesen GW, Hyman BT (1990). Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease. Prog Brain Res 83: 445-457.
52. Videbech P, Ravnkilde B (2004). Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry 161: 1957-1966.
53. Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET (2000). Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 157: 16-25.
54. Zeineh MM, Engel SA, Thompson PM, Bookheimer SY (2003). Dynamics of the hippocampus during encoding and retrieval of face-name pairs. Science 299: 577-580.